Director of BiostatisticsBioMarin Pharmaceutical Inc.Novato, California, United States
OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1
Monday, June 24, 202409:45 – 10:00 ICT